Ahrens Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ahrens Investment Partners's PFE Position: Q1 2023 in Review
Ahrens Investment Partners reduced its Pfizer (PFE) stake by 11% in Q1 2023, selling an estimated $27.1K and leaving 4,855 shares worth $198K. The position accounts for 0.1% of the portfolio, ranked #144.
Ahrens Investment Partners first reported a position in PFE in Q3 2017 and has held it in 18 quarters since. The position peaked at $522K in Q3 2018. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Ahrens Investment Partners held 4,855 shares of Pfizer worth $198K as of Q1 2023.
- Ahrens Investment Partners sold 628 Pfizer shares in Q1 2023, an estimated $27.1K.
- Pfizer made up 0.1% of Ahrens Investment Partners's portfolio in Q1 2023, its #144 holding.
- Ahrens Investment Partners first reported a position in Pfizer in Q3 2017 and has held it in 18 quarters since.
- Ahrens Investment Partners's Pfizer position peaked at $522K in Q3 2018.
- 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.